- Increase in the number of surgical procedures globally is driving sales opportunities in the global unfractionated heparin market
ALBANY, N.Y., March 23, 2022 (GLOBE NEWSWIRE) -- The global unfractionated heparin market is estimated to register growth at a CAGR of 6.4% during the forecast period, between 2019 and 2027, as per a study by Transparency Market Research (TMR).
The World Health Organization (WHO) states that due to prolonged travelling by train, airplane, and automobile for over four hours, the possibilities of an individual to develop venous thromboembolism are high. Coagulation disorders, including venous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, are known for affecting around 1 million U.S. population per year. In addition, the Centers for Disease Control and Prevention notes that around 500,000 to 900,000 people in the U.S. are experiencing health issues pertaining to VTE each year, states the TMR study on the global unfractionated heparin market.
Request Brochure of Unfractionated Heparin Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32198
The abovementioned data highlights that the need for reliable, safe, and cost-effective anticoagulants is expected to increase in the upcoming years. This, in turn, is projected to boost sales growth in the global unfractionated heparin market during the forecast period.
Companies operating in the global unfractionated heparin market are increasing investments in R&D activities in order to develop highly efficient products. Moreover, these efforts are also helping them in improving the quality of products they provide. Such factors are fueling the expansion of the global unfractionated heparin market.
Request for Analysis of COVID-19 Impact on Unfractionated Heparin Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=32198
Unfractionated Heparin Market: Key Findings
- Unfractionated heparin is naturally found anticoagulant that is being increasingly utilized for the prevention of blood clots in the heart lung and dialysis machines. Moreover, it is being used as an effectual solution in the treatment of different blood clotting disorders, including deep venous thrombosis and pulmonary embolism. Hence, rise in the number of people suffering from different blood clotting related diseases is resulting in a surge in the demand for unfractionated heparin across the globe, which, in turn, is propelling the global unfractionated heparin market.
- Biosimilar and generic manufacturers across the globe are projected to gain exceptional growth opportunities during the forecast period, owing to patent expiration for several unfractionated heparin globally. Owing to these factors, the unfractionated heparin market is expected to gain the valuation of US$ 1.7 Bn by 2027, notes the report by TMR. Furthermore, the market for unfractionated heparin is projected to be driven by the expansion of the pharmaceutical industry globally.
Get Exclusive PDF Sample Copy of Unfractionated Heparin Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32198
Unfractionated Heparin Market: Growth Boosters
- Rise in the number of surgical procedures globally is leading to profitable prospects in the unfractionated heparin market
- Increase in elderly population across the globe is likely to boost sales growth in the unfractionated heparin market
Unfractionated Heparin Market: Regional Analysis
- The unfractionated heparin market in Europe is prognosticated to gain profitable prospects during the forecast period, owing to surge in the prevalence of blood clot related diseases and rise in R&D activities in the region
- The Asia Pacific unfractionated heparin market is likely to expand at a rapid pace, owing to several factors such as increase in initiatives by regional governments for advancements in the healthcare industry, existence of several key players, and increase in older population in the region
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=32198
Unfractionated Heparin Market: Key Players
Some of the key players profiled in the report are:
- Dickinson and Company
- Becton
- Bio-Rad Laboratories, Inc
- bioMérieux S.A.
- EMD (Merck) Millipore
- Eiken Chemical Co, Ltd.
- Neogen Corporation
- Hi-Media Laboratories Pvt. Ltd.
- Scharlab S.L.
- Sigma-Aldrich Co. LLC
- Thermo Fisher Scientific
Unfractionated Heparin Market Segmentation
Source
- Bovine
- Porcine
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:
Heparin Market: The heparin market is estimated to reach a CAGR of 6.8% and gain a valuation of US$ 19.4 Bn. during the forecast period from 2019 to 2027. The heparin market is estimated to experience significant growth opportunities in the upcoming years. This market growth is on the back of various factors. Venous thromboembolism (VTM) has been highly common among the geriatric population, although it can take place at any age.
API Heparin Market: Heparin is an anticoagulant that is primarily used to prevent and treat venous thrombosis, pulmonary embolism, and other conditions of blood clotting. Heparin is the foremost clinical anticoagulant with more than 500 million doses consumed worldwide every year. Heparin and related molecules exhibit a large number of newly discovered biological activities with optimum therapeutic potential.
Crude Heparin Market: Heparin is a widely used, strongly charged polysaccharide anticoagulant agent. It is used as a drug and incorporated in devices. Heparin is used to treat and prevent blood clots caused by certain medical conditions or medical procedures. It is also used before surgery to reduce the risk of blood clots. Crude heparin is obtained primarily from bovine and porcine sources.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/unfractionated-heparin-drug-market.htm
